Articles dans des revues avec comité de lecture (80)
  1. 1. Allorant, A., Muset, P., Hodgins, C., Kirakoya, F., Namachapa, K., Mbofana, F., Panagiotoglou, D., Johnson, L. L., Imai-Eaton, J. J., & Maheu-Giroux, M. (2024). Temporal Trends and Determinants of HIV Testing at Antenatal Care in Sub-Saharan Africa: A Pooled Analysis of Population-Based Surveys (2005-2021). Journal of acquired immune deficiency syndromes, 95(1S), e97-e105. doi:10.1097/QAI.0000000000003329
  2. 2. Fassinou, L. C., Songwa Nkeunang, D., Delvaux, T., Nagot, N., & Kirakoya, F. (2024). Adherence to option B + antiretroviral therapy and associated factors in pregnant and breastfeeding women in Sub-Saharan Africa: a systematic review and meta-analysis. BMC public health, 24(1), 94. doi:10.1186/s12889-023-17004-9
  3. 3. Ouoba, K. J., Lankoandé-Haro, S., Fofana, S., Nacoulma, A. P., Kaboré, L., Sombié, I., Rouamba, T., & Kirakoya, F. (2024). Surveillance des effets indésirables lors des campagnes de la chimioprévention du paludisme saisonnier chez les enfants de 3-59 mois au Burkina Faso. Santé publique, 35(5), 121-132. doi:10.3917/spub.235.0121
  4. 4. Garanet, F., Samadoulougou, S., Ngwasiri, C., Coulibaly, A., B.Sissoko, F., Bagnoa, V., Baguiya, A., Kouanda, S., & Kirakoya, F. (2023). Perinatal outcomes in women with lower-range elevated blood pressure and stage 1 hypertension: insights from the Kaya health and demographic surveillance system, Burkina Faso. BMC public health, 23(1). doi:10.1186/s12889-023-17424-7
  5. 5. Fokam, A. F., Rouamba, T., Samadoulougou, S., Yé, Y., & Kirakoya, F. (2023). A Bayesian spatio-temporal framework to assess the effect of seasonal malaria chemoprevention on children under 5 years in Cameroon from 2016 to 2021 using routine data. Malaria journal, 22(1). doi:10.1186/s12936-023-04677-1
  6. 6. Ngwasiri, C., Kinoré, M., SAMADOULOUGOU OUINDPANGA, S., & Kirakoya, F. (2023). Sex-specific-evaluation of metabolic syndrome prevalence in Algeria: insights from the 2016–2017 non-communicable diseases risk factors survey. Scientific Reports, 13(1). doi:10.1038/s41598-023-45625-y
  7. 7. Larcin, L., Neven, A., Damase‐Michel, C., & Kirakoya, F. (2023). Belgian medication exposure during pregnancy ( BeMeP ), a new nationwide linked database: Linkage methods and prevalence of medication use. Pharmacoepidemiology and drug safety. doi:10.1002/pds.5705
  8. 8. Ridde, V., Fillol, A., Kirakoya, F., & Hane, F. (2023). Agir pour une décolonisation de la santé mondiale en France… et ailleurs. Santé publique, Vol. 35(2), 109-113. doi:10.3917/spub.232.0109
  9. 9. Hoogstoel, F., SAMADOULOUGOU OUINDPANGA, S., Diouf, A., Savoye, I., Donnen, P., Van der Heyden, J., & Kirakoya, F. (2023). Adherence to ‘5-2-1-0’ guidelines and multiple risky behaviours among adolescents in nine sub-Saharan African countries: evidence from Global School-based Student Health Survey 2012–2017. BMJ nutrition, prevention & health, 6(1), 91-99. doi:10.1136/bmjnph-2022-000488
  10. 10. Halidane, C., Bluteau, J., Pillarella, S., & Kirakoya, F. (2023). Impact of flexible seating on the quality of teacher-student interactions with coping to stress adaptation and mental health of elementary students in Quebec. International journal of health promotion and education, 1-14. doi:10.1080/14635240.2023.2212373
  11. 11. Cisse, K., Samadoulougou, S., Kaboré, J., Somda, P., Zongo, A. Z., Traoré, S., Zabsonre, P., Yombi, J. C., Kouanda, S., & Kirakoya, F. (2023). Healthcare system's preparedness to provide cardiovascular and diabetes-specific care in the context of geopolitical crises in Burkina Faso: a trend analysis from 2012 to 2018. BMJ open, 13(5), e065912. doi:10.1136/bmjopen-2022-065912
  12. 12. Ukwishaka, J., Ndayishimiye, Y., Destine, E., Danwang, C., & Kirakoya, F. (2023). Global prevalence of coronavirus disease 2019 reinfection: a systematic review and meta-analysis. BMC public health, 23(1), 778. doi:10.1186/s12889-023-15626-7
    13. << Précédent 1 2 3 4 5 6 7 8 9 10 Suivant >>